IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 15 filers reported holding IMMUCELL CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $975,000 | -24.8% | 175,000 | -12.3% | 0.07% | -22.1% |
| Q2 2019 | $1,297,000 | +2.4% | 199,600 | 0.0% | 0.10% | +1.1% |
| Q1 2019 | $1,267,000 | -9.9% | 199,600 | 0.0% | 0.09% | -19.0% |
| Q4 2018 | $1,406,000 | -15.5% | 199,600 | 0.0% | 0.12% | +4.5% |
| Q3 2018 | $1,663,000 | +22.2% | 199,600 | 0.0% | 0.11% | +23.3% |
| Q2 2018 | $1,361,000 | -2.6% | 199,600 | 0.0% | 0.09% | -4.3% |
| Q1 2018 | $1,397,000 | -20.4% | 199,600 | 0.0% | 0.09% | -16.8% |
| Q4 2017 | $1,754,000 | +19.9% | 199,600 | -11.3% | 0.11% | +18.9% |
| Q3 2017 | $1,463,000 | -11.3% | 225,000 | 0.0% | 0.10% | -10.4% |
| Q2 2017 | $1,649,000 | +32.6% | 225,000 | 0.0% | 0.11% | +39.5% |
| Q1 2017 | $1,244,000 | -7.1% | 225,000 | 0.0% | 0.08% | +2.7% |
| Q4 2016 | $1,339,000 | -23.0% | 225,000 | 0.0% | 0.07% | -26.0% |
| Q3 2016 | $1,739,000 | +23.0% | 225,000 | +9.8% | 0.10% | +25.0% |
| Q2 2016 | $1,414,000 | +1.7% | 204,972 | +0.9% | 0.08% | +9.6% |
| Q1 2016 | $1,391,000 | – | 203,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |